The Efficacy and Safety of Hypertonic Saline in Cardiac Surgery Patients.

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Coronary Artery DiseaseEdema
Interventions
DRUG

7.2% NaCl plus 6% hydroxyethyl starch 200/0.5

DRUG

0.9% NaCl

Trial Locations (1)

630055

Novosibirsk Research Institute of Pathology of Circulation, Novosibirsk

All Listed Sponsors
lead

Meshalkin Research Institute of Pathology of Circulation

NETWORK

NCT01675453 - The Efficacy and Safety of Hypertonic Saline in Cardiac Surgery Patients. | Biotech Hunter | Biotech Hunter